These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26723110)

  • 1. Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90-01 Randomized Trial.
    Cotte E; Passot G; Decullier E; Maurice C; Glehen O; François Y; Lorchel F; Chapet O; Gerard JP
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):544-53. PubMed ID: 26723110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.
    Ortholan C; Romestaing P; Chapet O; Gerard JP
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e165-71. PubMed ID: 22579379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial.
    Francois Y; Nemoz CJ; Baulieux J; Vignal J; Grandjean JP; Partensky C; Souquet JC; Adeleine P; Gerard JP
    J Clin Oncol; 1999 Aug; 17(8):2396. PubMed ID: 10561302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
    Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders.
    Rengan R; Paty PB; Wong WD; Guillem JG; Weiser M; Temple L; Saltz L; Minsky BD
    Clin Colorectal Cancer; 2006 Mar; 5(6):413-21. PubMed ID: 16635280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
    Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
    Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of tumor fixation of rectal carcinoma. Implications for adjunctive radiation therapy.
    Mohiuddin M; Regine WF; Marks G
    Cancer; 1996 Aug; 78(4):717-22. PubMed ID: 8756362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Timing of Surgical Resection After Radiation in Locally Advanced Rectal Adenocarcinoma: An Analysis of the National Cancer Database.
    Huntington CR; Boselli D; Symanowski J; Hill JS; Crimaldi A; Salo JC
    Ann Surg Oncol; 2016 Mar; 23(3):877-87. PubMed ID: 26514119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
    Zhan T; Gu J; Li M; Du C
    Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
    Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes after intersphincteric resection for low-lying rectal cancer.
    Saito N; Ito M; Kobayashi A; Nishizawa Y; Kojima M; Nishizawa Y; Sugito M
    Ann Surg Oncol; 2014 Oct; 21(11):3608-15. PubMed ID: 24923221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.